ADAPTIVE BIOTECHNOLOGIES CORPORATION: cashflow_investing

Value{"amount": 9143000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2026-01-01 – 2026-03-31
Statuscurrent
EntityADAPTIVE BIOTECHNOLOGIES CORPORATION
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-26-206546
Retrieved: 2026-08-19T14:40:41.432875+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001478320/cashflow-investing/2026-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e1c52ae5-1b44-435e-9382-ad6f0893bb8c

History